• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
Diabeto-Cardiology

Diabeto-Cardiology

A Companion to Braunwald's Heart Disease

9780323878623
892.03 zł
758.23 zł Save 133.80 zł Tax included
Lowest price within 30 days before promotion: 758.23 zł
Quantity
Teaser
2026-03-18

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Part of the renowned Braunwald family of references, Diabeto-Cardiology, 2nd Edition, provides today’s clinicians with clear, authoritative guidance on the complex challenges of providing care to patients with cardiovascular and diabetes co-morbidities. Drs. Darren K. McGuire and Nikolaus Marx, along with a leading team of experts in cardiology and diabetes, address both the foundational aspects and clinical implications for this growing number of patients, including recent breakthrough therapies and new medications that have contributed to newer and more effective treatments and improved patient outcomes. From cover to cover, this second edition offers reliable and current point-of-care coverage of the interwoven care needs of patients with these complex co-morbidities, making it an ideal resource for practitioners at all levels of experience.
Product Details
Saunders
104229
9780323878623
9780323878623

Data sheet

Publication date
2025
Issue number
2
Cover
hard cover
Pages count
416
Dimensions (mm)
216 x 276
Weight (g)
450
  • Section 1 Diabetes Mellitus
    1. Definition and Epidemiology of Type 2 Diabetes Mellitus
    2. Insulin Resistance: Pathophysiology, Molecular Mechanisms, Genetic Insights
    3. Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus
    4. Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes?
    5. Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease

    Section 2 Cardiovascular Complications of Type 2 Diabetes
    6. Atherosclerosis in Patients with Type 2 Diabetes: Epidemiology
    7. Pathology and Vascular Biology of Atherosclerosis in Patients with Type 2 Diabetes: Inflammation, Dyslipidemia, Hypercoagulability, Endothelial Dysfunction, and Inflammation
    8. Risk Stratification Among Patients with Type 2 Diabetes with or at Risk for Atherosclerotic Cardiovascular Disease
    9. Epidemiology and Pathophysiology of Heart Failure with Preserved and with Reduced Ejection Fraction in Patients with Type 2 Diabetes

    Section 3 Effects of Antihyperglycemic Therapies for Type 2 Diabetes on Cardiovascular and Kidney Outcomes
    10. Effect of Acute and Chronic Glucose Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
    11. Regulatory Approach to Medications for Type 2 Diabetes: Past, Present and Future
    12. Cardiovascular and Kidney Effects of Sodium Glucose Co-transporter Inhibitors
    13. Cardiovascular and Kidney Effects of Glucagon-like Peptide 1 Receptor Agonists
    14. Antihyperglycemic Medications with Proven Cardiovascular Safety
    15. Prevention of Heart Failure in Patients with Type 2 Diabetes
    16. Treatment of Patients with Reduced and with Preserved Ejection Fraction Heart Failure in Patients with Type 2 Diabetes

    Section 4 Management of Coronary Heart Disease Risk, Chronic and Acute Coronary Syndromes in Patients with Type 2 Diabetes
    17. Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
    18. Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
    19. Effect of Lipid Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
    20. Effect of Antiplatelet and Anticoagulant Therapies on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
    21. Therapeutic Implications of Type 2 Diabetes for Patients Undergoing Percutaneous or Surgical Coronary Revascularization
    22. Epidemiology of Acute Coronary Syndromes in Patients with Type 2 Diabetes
    23. Antiplatelet and Anticoagulant Therapy in Patients with Type 2 Diabetes with Acute Coronary Syndromes and/or Percutaneous Coronary Intervention

    Section 5 Other Cardiovascular Considerations Associated with Type 2 Diabetes
    24. Peripheral Artery Disease in Patients with Type 2 Diabetes
    25. Cerebrovascular Disease in Patients with Type 2 Diabetes
    26. Atrial Fibrillation in Patients with Type 2 Diabetes
    27. Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients with Type 2 Diabetes
    28. Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Women, Race/Ethnic Minorities, and the Elderly
    29. The Quality Chasm - Type 2 Diabetes
Comments (0)